Submissions

1. TYPES OF MANUSCRIPTS

Feline Coronaviruses: Research, Pathogenesis and Therapeutics welcomes original and scholarly contributions that advance the understanding of Feline Coronavirus (FCoV) biology, epidemiology, pathogenesis, diagnostics, therapeutics, and clinical management. The journal embraces a broad, interdisciplinary perspective, integrating virology, immunology, molecular biology, pharmacology, epidemiology, and clinical veterinary medicine.

The journal considers the following types of manuscripts:

Original Research Articles
Full-length reports of original empirical or theoretical research on any aspect of FCoV or FIP. Manuscripts should present novel findings, rigorous methodology, and substantive contributions to the field.

Comprehensive Reviews
Critical and systematic reviews of established and emerging literature on FCoV-related topics. Reviews should synthesize existing knowledge, identify research gaps, and propose future directions. Meta-analyses and systematic reviews with clear methodologies are encouraged.

Short Communications
Concise but complete reports of preliminary findings, novel observations, or methodological innovations. These manuscripts should be no longer than 2,500 words and follow the same structural rigor as full-length articles.

Case Reports
Detailed clinical case reports describing unusual or instructive presentations of FCoV infection or FIP. Reports should include comprehensive clinical history, diagnostic findings, treatment protocols, and outcomes. A brief literature review contextualizing the case is required.

Hypothesis & Theory Articles
Manuscripts proposing new hypotheses, theoretical frameworks, conceptual models, or interpretations that may stimulate further research and debate in FCoV and FIP science.

Methodological Notes
Short communications introducing innovative or emerging research methods applicable to FCoV research, including novel diagnostic assays, molecular techniques, in vitro/in vivo models, bioinformatics tools, or statistical approaches.

Commentaries
Critical scholarly commentaries on previously published articles, significant developments, emerging issues, or controversies within the journal's scope.

Letters to the Editor
Concise scholarly communications addressing issues related to articles published in the journal, methodological or theoretical matters, or topics of significant interest to the FCoV research community.

Book Reviews
Critical evaluations of recently published scholarly books (within the last 2 years) relevant to FCoV, FIP, coronavirology, or feline infectious diseases.

2. PREPARATION OF ARTICLES

Authors are strongly encouraged to carefully follow the guidelines outlined in this document. Adherence to these guidelines will enhance the clarity, coherence, and academic quality of submissions and is essential for maintaining the standards of the journal.

Mandatory Article Template
All articles submitted to this journal must be prepared using the template provided below. Articles not using this template will not be accepted for the review stage. Please also use this template file when uploading your manuscript to the online submission system.

Important Notes

• Mandatory Template: All manuscripts must be prepared according to the official template provided.

• All Sections: The title, author information, abstract, keywords, headings, text, references, and all other sections must strictly adhere to the rules and formatting (font, point size, style, alignment, etc.) specified in the template.

• Submission Process: You must upload your manuscript to the online submission system formatted according to the required template.

• Articles should be comprehensive, fully documented reports of original research. They should be concise but with complete results and conclusions. Authors are encouraged to take advantage of web features available (including data visualizations, supplementary data, or video abstracts).

• Manuscripts should be divided into the following sections: Title page, Abstract, Introduction, Materials and Methods, Results, Discussion, Conclusion, Acknowledgments, References.

3. ARTICLE SECTIONS

Article Title
The title should clearly and concisely reflect the content of the article. Titles are very important for current awareness and information retrieval and therefore should be carefully constructed for these purposes. Include key terms such as "Feline Coronavirus," "FCoV," or "FIP" where appropriate.

Names and Addresses
For multiple-authored articles, list the names and affiliations of all the authors, the email address(es), and the full postal addresses, using identifiers to link an author with an address where necessary. All authors must provide their ORCID iD.

Abstract
Articles have an abstract, separate from the text, that should not contain any references, numbers, abbreviations, or acronyms unless absolutely necessary.

• For empirical research articles (including Original Research, Short Communications, Case Reports): The abstract should be structured with the following subheadings: Background / Objectives, Methods, Results, Conclusion.

• For review articles and theoretical essays: The abstract should be unstructured, summarizing the main argument, scope, and contribution.

The abstract should give readers concise information about the content of the article. When preparing their abstracts, authors should keep in mind that this summary is aimed at a diverse audience, including virologists, clinicians, immunologists, and epidemiologists. The abstract is the most important section of the paper since it will be widely and freely disseminated by scientific indexing systems and will be read far more often than the whole paper.

Keywords
All authors are required to provide 4–6 keywords characterizing the topic of their article. Immediately after the abstract, provide keywords using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible (e.g., FCoV, FIP, GS-441524). These keywords will be used for indexing purposes.

Introduction
The introduction should include a statement explaining the motivation for the research and should accurately place the investigations in context with previous or current work in the field. Clearly state the research problem, research questions/hypotheses, and the significance of the study. Emphasize the relevance to FCoV biology, FIP pathogenesis, or clinical applications.

Materials and Methods
This section provides a clear, unambiguous description of:

• Study design and experimental approach

• Animals/samples/clinical cases (including ethical approvals, informed consent, and institutional animal care committee approvals)

• Viral isolates, cell lines, or reagents used

• Diagnostic assays, molecular techniques (RT-qPCR, sequencing, etc.)

• Antiviral compounds and treatment protocols (dosages, routes, schedules)

• Statistical analyses and data presentation

• Ethical considerations (animal welfare, informed consent for clinical cases, institutional review board approval)

Provide sufficient detail to permit reproduction of the work. Cite established methods and provide references for modifications.

Results
Present your findings clearly and objectively. Use tables and figures to supplement the text, but do not repeat all data in both formats. Do not interpret or discuss the results in this section. Organize results logically, using subheadings where appropriate.

Discussion
Interpret your findings in light of the theoretical framework and existing literature. Discuss the implications, limitations, and significance of your study. Address how the findings advance understanding of FCoV biology, FIP pathogenesis, diagnostics, or therapeutics. Compare with previous studies and explain discrepancies.

Conclusion
This last section should outline succinctly the key findings, present possible important applications of the work (e.g., clinical practice, diagnostic algorithms, treatment protocols), suggestions for future research studies, and reflections on new challenges for the field.

Acknowledgments
All contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section.

Funding
All sources of funding must be disclosed at the end of the main text under a separate heading Funding. Include grant numbers and funding agency names.

Conflict of Interest Declaration
All authors must declare any potential conflicts of interest. If none exist, state: "The authors declare no conflicts of interest."

4. REFERENCES – AUTHOR-DATE STYLE

Feline Coronaviruses: Research, Pathogenesis and Therapeutics uses the author-date citation system (similar to APA/Harvard style). This system uses in-text citations consisting of the author's surname and the year of publication in parentheses.

In-Text Citations

• Single author: (Pedersen, 2020)

• Two authors: (Pedersen & Hartmann, 2020)

• Three or more authors: (Pedersen et al., 2020)

• Multiple citations: Order alphabetically and separate with semicolons: (Addie et al., 2019; Pedersen, 2020; Tasker, 2018)

• Multiple works by same author in same year: Use letters to distinguish: (Pedersen, 2020a, 2020b)

• Direct quotation: Include page number: (Pedersen, 2020, p. 45)

Reference List

• Order: Alphabetical by the first author's surname.

• Format: List only the references that are actually cited in the text. Do not include a separate bibliography.

• Authors: List all authors up to 20. For more than 20, list the first 19 followed by "..." and then the last author.

• Journal Title: Full journal name (do not abbreviate).

Reference Samples (Author-Date Style)

Web References
As a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.) should also be given.

5. MATHEMATICS, SYMBOLS, AND TABLES

Mathematics and Symbols
If your article contains superscripts or subscripts (e.g., viral titers, concentration units, genetic notation), take special care to ensure that the positioning of the characters is unambiguous. If special symbols are needed (e.g., Greek characters, accented characters, or mathematical symbols), these should be typed using the appropriate TrueType font. Equations must be prepared using Equation Editor or MathType.

Tables

• Tables must be editable (do not embed them as images).

• Number tables consecutively in the order they are cited in the text (Table 1, Table 2, etc.).

• Provide a concise, descriptive title above each table.

• Use horizontal lines only; avoid vertical lines or complex borders.

• Include clear column headings and, if necessary, footnotes to explain abbreviations or statistical notations.

Figures

• Figures include charts, graphs, maps, photographs, and diagrams. In veterinary and virological research, illustrative materials should be included only when they are strictly necessary for clarifying the discussion.

• Submit figures as high-resolution files: minimum 300 dpi for photographs and 600 dpi for line art.

• Acceptable file formats: .jpeg, .tiff, .eps, or .pdf.

• Number figures consecutively (Figure 1, Figure 2, etc.).

• Provide a brief but clear caption below each figure.

• If reproducing copyrighted material (e.g., published images, microscopy photographs, or diagnostic images), authors are responsible for obtaining written permission from the copyright holder.

6. PROOFS

Proofs of articles are usually sent to you for correction by e-mail as an annotated Microsoft Word *.doc or *.docx file attachment. When checking your proofs, you should take particular care checking virological nomenclature, genetic sequences, drug dosages, statistical data, tables, and references. Only essential corrections should be made.

7. ACKNOWLEDGEMENTS AND FUNDING

Acknowledgements
All contributors who do not meet the criteria for authorship should be listed in the Acknowledgements section. This includes technical staff, veterinary nurses, laboratory technicians, and colleagues who provided critical feedback but did not qualify as co-authors.

Funding
All sources of funding must be disclosed at the end of the main text under a separate heading Funding. Include grant numbers and funding agency names. If no funding was received, state: "This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors."

8. SPECIFIC GUIDELINES FOR MANUSCRIPT TYPES

Original Research Articles
This is the main section of the journal. Original empirical or theoretical research on any aspect of FCoV or FIP. Full-length articles should not normally exceed 6,000 words (excluding references, tables, and figures).

Comprehensive Reviews
Comprehensive critical literature reviews, systematic reviews, or meta-analyses offering new perspectives on significant FCoV or FIP debates. Rather than a 'collage' of detailed information with a complete literature survey, a critically selected treatment of the material is desired; unsolved problems and possible developments should also be discussed. Reviews should not normally exceed 8,000 words.

Short Communications
Concise but complete reports of preliminary findings, novel observations, or methodological innovations. These manuscripts should be no longer than 2,500 words, with no more than 3 tables/figures and up to 30 references.

Case Reports
Detailed clinical case reports describing unusual or instructive presentations of FCoV infection or FIP. Follow the CARE (CAse REport) guidelines where applicable. Include comprehensive clinical history, diagnostic findings, treatment protocols, and outcomes. A brief literature review contextualizing the case is required. Case reports should not exceed 2,500 words.

Hypothesis and Theory Articles
Articles proposing new hypotheses, theoretical frameworks, conceptual models, or interpretations. A hypothesis is a fresh, unchallenged idea that a scientist proposes prior to conducting research. A theory, on the other hand, is a substantiated explanation for an occurrence.

Methodological Notes
Short communications introducing innovative or emerging research methods applicable to FCoV research, including novel diagnostic assays, molecular techniques, in vitro/in vivo models, bioinformatics tools, or statistical approaches. Maximum 2,000 words.

Commentaries
Critical or scholarly commentaries on previously published articles, significant developments, theoretical debates, or emerging issues within the journal's scope. Maximum 1,500 words.

Letters to the Editor
Concise scholarly communications addressing issues related to articles published in the journal, methodological or theoretical matters, or topics of significant interest. Maximum 800 words.

Book Reviews
Critical evaluations of recently published scholarly books (within the last 2 years) relevant to FCoV, FIP, coronavirology, or feline infectious diseases. Reviews should include specification of the publisher, author, number of pages, date of publication, and price as appropriate. Maximum 1,000 words.

9. REFEREEING PROCESS

Feline Coronaviruses: Research, Pathogenesis and Therapeutics employs a rigorous double-anonymized peer review process. All contributions that are selected for peer review are sent to at least two independent reviewers with expertise in the relevant fields (virology, immunology, veterinary medicine, pharmacology, etc.).

Anonymization Requirements:

• Do NOT include the author's name, affiliation, or acknowledgment section in the main manuscript file.

• Remove author-identifying information from the document properties (File > Info > Check for Issues > Inspect Document).

• Self-citations: Cite your own previous work in the third person and without revealing authorship (e.g., "As previously demonstrated (Pedersen et al., 2019)").

• Do not include any identifying information in figure file names or metadata.

Review Process Timeline:

• Initial Editorial Review: 1–2 weeks

• Peer Review: 4–6 weeks

• Editorial Decision: 1–2 weeks after review completion

• Publication Online: Within 4 weeks of acceptance

10. ARTICLE PROCESSING CHARGES (APC)

Feline Coronaviruses: Research, Pathogenesis and Therapeutics charges Article Processing Charges (APC) but does not charge submission fees. This policy benefits authors, as payments are only required once a manuscript has been accepted for publication. Book reviews, Commentaries, and invited articles are fully exempt from APCs. In addition, APCs are not charged for articles authored by members of the editorial board. To support the costs of maintaining the publication infrastructure, managing the journal, and overseeing the peer-review and editorial processes, an APC is charged upon acceptance of a manuscript. For the most current APC rates and waivers, please visit our website or contact the editorial office.

Waiver Policy: Limited waivers are available for authors from low-income countries or those facing financial hardship. Please contact the editorial office before submission to inquire about waiver eligibility.

11. SUBMISSION AND PUBLICATION WORKFLOW

Prepare your paper for submission
Please use the article template when preparing your article. Also use it during online submission. The preparation of your article in the form of these formal rules is important for editorial first look/opinion and referee evaluation.

Submit and revise
You can submit to Feline Coronaviruses: Research, Pathogenesis and Therapeutics using our online systems.

Track your submitted paper
You can track the status of your submitted paper online. The system you use to track your submission will be the same system to which you submitted.

Track your accepted paper
Once your paper is accepted for publication, you will receive an email and a direct link that lets you follow its publication status.

Share and promote
Now that your article is published, you can promote it to achieve a bigger impact for your research. Share on social media, institutional repositories, and academic networks.

COPYRIGHT NOTICE

Feline Coronaviruses: Research, Pathogenesis and Therapeutics is committed to the principles of open access and to ensuring that authors retain full control over their intellectual property. By submitting a manuscript to the journal, authors agree to the terms of the journal's copyright and licensing policy. All authors are required to confirm their agreement with this notice before their submission is complete.

Authors Retain Copyright
Authors continue to hold full copyright to their work with no restrictions. By submitting to the journal, authors grant the journal the right of first publication. However, the final published version of the article is made available to the public under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). This means that authors retain ownership of their work while allowing others to share and adapt it for non-commercial purposes, provided proper attribution is given.

Creative Commons License
All articles published in the journal are distributed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). This license allows others to share, copy, distribute, and transmit the work, as well as to remix, transform, and build upon the work for non-commercial purposes, as long as they credit the original authors and the journal as the original publisher. The license ensures that research is freely accessible to anyone with internet access, maximizing dissemination and impact. It is consistent with the Budapest Open Access Initiative definition of open access and is designed to support the global exchange of knowledge.

Author Rights and Reuse
Under this policy, authors may publish the final published version of their article in any repository, on any website, or in any other platform, provided that a complete citation to the original publication in the journal is given. Authors may also distribute, remix, adapt, and build upon their work for non-commercial purposes, as long as they credit the journal as the original publisher. Authors retain the right to be properly acknowledged and cited, and to control the integrity of their work.

Commercial Use
The CC BY-NC 4.0 license does not permit commercial use of the published material without explicit permission from the authors and the journal. Commercial use includes, but is not limited to, selling the work, using it in advertising, or incorporating it into commercial products. If you wish to use the work for commercial purposes, please contact the editorial office to discuss permissions.

Author's Confirmation
Before their submission is complete, authors will be required to confirm that they agree with the copyright notice. This confirmation is a mandatory step in the submission process. By confirming, authors acknowledge that they have read and understood the copyright and licensing policy and agree to its terms. Authors also confirm that they have the authority to grant the rights described in this notice and that the submission does not infringe on any third-party rights.

Responsibilities of Authors
Authors are responsible for ensuring that their work is original, does not infringe on any copyright, and complies with all applicable laws. Authors must also ensure that they have obtained permission to use any third-party material included in their manuscript, such as figures, tables, or text excerpts. Any third-party material must be properly attributed, and authors must provide evidence of permission if requested.

PRIVACY STATEMENT

Feline Coronaviruses: Research, Pathogenesis and Therapeutics is committed to protecting the privacy, confidentiality, and security of personal information provided by authors, reviewers, editors, readers, and other users of the journal website and editorial platform.

This Privacy and Data Protection Policy explains what information may be collected through the journal website and online editorial system, how such information is used, how it is protected, and the circumstances under which it may be disclosed.

The journal processes personal information only for legitimate and clearly defined purposes related to the operation, administration, editorial evaluation, peer review, publication, dissemination, and improvement of the journal.

1. Scope of This Policy
This policy applies to personal information collected through the journal website, online submission and peer-review system, editorial correspondence, article publication services, and other journal-related interactions.

The journal uses personal information only for purposes associated with its scholarly and publishing activities. Personal information will not be sold, rented, or disclosed to unrelated third parties for commercial purposes.

Where external services are used to support website functionality, analytics, communication, or publishing operations, such services may process limited technical or personal information in accordance with their own privacy policies and applicable data-protection requirements.

2. Information We May Collect
Depending on how you interact with the journal, we may collect different categories of information.

2.1 Website and Technical Information
When visitors access the journal website, certain technical information may be automatically processed for security, functionality, performance monitoring, and statistical purposes.

This may include:

• IP address

• device type and technical identifiers

• browser type and version

• operating system and language settings

• screen resolution

• date and time of access

• pages and resources accessed

• referring website or URL

• search queries or other technical requests

• information concerning website functionality and performance

Such information is used primarily in aggregated or anonymized form to maintain website security, improve usability, diagnose technical problems, and understand general patterns of website use.

The journal seeks to minimize the amount of personal information collected and processed and does not intentionally collect personal information that is unnecessary for the stated purposes.

3. User Registration and Personal Accounts
Users who register for an account with the journal may be asked to provide information necessary to establish and maintain their account.

This may include:

• full name

• username

• email address

• institutional affiliation

• professional information

• account credentials

• correspondence with the journal

• information voluntarily provided through the user profile

Login credentials are used to authenticate users and provide access to appropriate journal functions.

Users are responsible for maintaining the confidentiality of their account credentials and should notify the journal if they believe that their account has been accessed without authorization.

4. Manuscript Submission and Peer Review
The journal operates an online manuscript submission and peer-review system. To provide these services, the journal may process information associated with authors, reviewers, editors, and manuscripts.

Depending on the user's role, this may include:

• name and professional affiliation

• email address

• username and account information

• manuscript files

• cover letters

• supplementary materials

• reviewer reports and editorial correspondence

• author contribution information

• funding information

• conflict-of-interest declarations

• ethical approval information

• institutional or professional affiliations

• communications exchanged during editorial assessment and publication

This information is processed solely for legitimate scholarly publishing purposes, including submission management, editorial assessment, peer review, production, publication, indexing, archiving, and scholarly communication.

5. Confidentiality of Peer Review
Information associated with manuscripts under review is treated as confidential.

Editors and reviewers are expected to maintain the confidentiality of unpublished manuscripts and must not use unpublished information obtained through the editorial or peer-review process for personal, professional, or financial advantage.

The journal's peer-review procedures are governed by its Publication Ethics and Editorial Policies.

Personal information relating to authors and reviewers will not be disclosed unnecessarily to individuals outside the editorial and publishing processes.

6. Use of Personal Information
Personal information may be used for legitimate journal-related purposes, including:

• managing user accounts

• processing manuscript submissions

• conducting peer review

• communicating with authors and reviewers

• administering editorial decisions

• preparing manuscripts for publication

• publishing and disseminating scholarly content

• maintaining the integrity of the scholarly record

• responding to inquiries

• managing subscriptions or journal communications where applicable

• improving website functionality and performance

• monitoring website security

• generating anonymized and aggregated usage statistics

• complying with legal or regulatory requirements

The journal does not use personal information for unrelated commercial purposes.

7. Email Communications and Newsletters
Users may receive communications necessary for the operation of their account, manuscript submission, peer review, publication, or other journal-related activities.

Where newsletters or other optional communications are offered, users will receive such communications only where appropriate consent or another lawful basis exists.

Users may unsubscribe from optional newsletters or promotional communications by using the unsubscribe mechanism provided in the relevant communication.

Unsubscribing from optional communications does not prevent the journal from sending essential correspondence relating to manuscripts, peer review, editorial decisions, or account administration.

8. Cookies and Similar Technologies
The journal website may use cookies and similar technologies to support essential website functionality, security, user authentication, preferences, and analytics.

Cookies may allow the website to recognize a user's browser or maintain a session during website use.

Where required, non-essential cookies and analytics technologies will be used in accordance with applicable consent requirements.

Users may manage or disable cookies through their browser settings. Disabling certain cookies may affect the functionality of some areas of the website.

9. Website Analytics
The journal may use third-party analytics services, such as Google Analytics, to understand general patterns of website usage and improve website performance and functionality.

Depending on the configuration of the analytics service and the user's consent preferences, information processed may include:

• IP address or truncated IP information

• cookie or online identifiers

• device information

• browser and operating-system information

• referring URL

• pages visited

• session duration

• interaction with website features

• downloads and other aggregated usage information

Analytics information is used primarily to evaluate website performance, understand readership patterns, improve the user experience, and develop journal services.

Where applicable, the journal uses available privacy-enhancing configuration options, including IP anonymization or truncation.

The journal may retain historical analytics information in anonymized or pseudonymized form for statistical and research purposes where permitted by applicable law.

10. Social Media and External Services
The journal may provide links or sharing functionality connecting the website with external social-media platforms or other third-party services.

When users interact with an external platform, that platform may independently collect and process information according to its own privacy policy and terms of service. The journal does not control the privacy practices of external providers.

Users are encouraged to review the privacy policies of third-party services before using their features or submitting personal information through those services.

11. Data Security
The journal takes reasonable technical and organizational measures to protect personal information against unauthorized access, alteration, disclosure, loss, misuse, or destruction.

Access to personal information is limited to individuals who require such information to perform legitimate editorial, publishing, administrative, technical, or legal functions.

Although reasonable safeguards are implemented, no internet-based system can be guaranteed to be completely secure. Users should therefore exercise appropriate caution when transmitting information online.

12. Data Retention
Personal information is retained only for as long as reasonably necessary to fulfil the purposes for which it was collected, to maintain the scholarly record, to operate the journal, or to comply with applicable legal, regulatory, accounting, or archival requirements.

Where no specific retention period is prescribed, information will be retained only for the period necessary to fulfil the relevant legitimate purpose.

Certain information associated with published scholarly articles may be retained permanently or for extended periods because preservation of the scholarly record is an essential function of academic publishing.

13. Disclosure of Personal Information
The journal does not sell personal information or disclose it to unrelated third parties for commercial purposes.

Personal information may be disclosed when necessary to:

• provide journal and publishing services

• operate the online submission and peer-review system

• provide technical or hosting services

• support indexing, archiving, and scholarly dissemination

• protect the security and integrity of the journal

• investigate suspected publication misconduct

• comply with legal obligations or valid legal requests

Where external service providers process personal information on behalf of the journal, appropriate safeguards will be applied to the extent reasonably possible.

14. International Data Transfers
Because the journal operates within an international scholarly publishing environment, personal information may be processed or stored in jurisdictions outside the country in which a user is located.

Where international transfers occur, the journal seeks to apply appropriate safeguards consistent with applicable data-protection requirements.

15. User Rights
Subject to applicable law, individuals may have rights concerning their personal information, including the right to:

• request access to personal information held about them

• request correction of inaccurate or incomplete information

• request deletion where legally applicable

• object to or restrict certain processing activities

• withdraw consent where processing is based on consent

• request information concerning the processing of their personal information

Requests concerning personal information should be submitted to the journal using the contact information provided below. Certain requests may be subject to legal, contractual, editorial, or archival limitations.

16. Children's Privacy
The journal is an academic scholarly publication and is not directed toward children. The journal does not knowingly seek to collect personal information from children through its website or submission system.

17. Changes to This Policy
The journal may periodically revise this Privacy and Data Protection Policy to reflect changes in publishing practices, website functionality, technology, legal requirements, or data-protection standards.

Any revised version will be published on this page with an updated revision date.